Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edesa Biotech Inc (EDSA)
NASDAQ:EDSA
Holding EDSA?
Track your performance easily
EDSA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.05 - $6.46
Previous Close$2.2
Volume4.76K
Average Volume (3M)22.81K
Market Cap
$6.66M
Enterprise Value$5.11M
Total Cash (Recent Filing)$2.04M
Total Debt (Recent Filing)$38.82K
Price to Earnings (P/E)―
Beta0.42
Next Earnings
Dec 13, 2024EPS Estimate
-$0.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.72
Shares Outstanding3,215,968
10 Day Avg. Volume20,289
30 Day Avg. Volume22,807
Standard Deviation0.28
R-Squared0.03
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.47
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.76
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Edesa Biotech News
PremiumCompany Announcements
Edesa Biotech Gains CEO’s Strategic Investment Boost
PremiumCompany Announcements
Edesa Biotech to Present at Global ConferencesPremiumCompany Announcements
Edesa Biotech Partners with Wainwright for Share Sales
PremiumCompany Announcements
Edesa Biotech Showcases Steady Q3 2024 Financials
Ownership Overview
40.98% Insiders
1.38% Mutual Funds
3.39% Other Institutional Investors
53.77% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
EDSA FAQ
What was Edesa Biotech Inc’s price range in the past 12 months?
Edesa Biotech Inc lowest stock price was $2.05 and its highest was $6.46 in the past 12 months.
What is Edesa Biotech Inc’s market cap?
Currently, no data Available
When is Edesa Biotech Inc’s upcoming earnings report date?
Edesa Biotech Inc’s upcoming earnings report date is Dec 13, 2024 which is in 21 days.
How were Edesa Biotech Inc’s earnings last quarter?
Edesa Biotech Inc released its earnings results on Aug 09, 2024. The company reported -$0.52 earnings per share for the quarter, beating the consensus estimate of -$0.58 by $0.06.
Is Edesa Biotech Inc overvalued?
According to Wall Street analysts Edesa Biotech Inc’s price is currently Overvalued.
Does Edesa Biotech Inc pay dividends?
Edesa Biotech Inc does not currently pay dividends.
What is Edesa Biotech Inc’s EPS estimate?
Edesa Biotech Inc’s EPS estimate is -$0.54.
How many shares outstanding does Edesa Biotech Inc have?
Edesa Biotech Inc has 3,247,389 shares outstanding.
What happened to Edesa Biotech Inc’s price movement after its last earnings report?
Edesa Biotech Inc reported an EPS of -$0.52 in its last earnings report, beating expectations of -$0.58. Following the earnings report the stock price went down -4.752%.
Which hedge fund is a major shareholder of Edesa Biotech Inc?
Currently, no hedge funds are holding shares in EDSA
---
Edesa Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.86%
12-Months-Change
Fundamentals
Return on Equity
-129.29%
Trailing 12-Months
Asset Growth
-44.50%
Trailing 12-Months
Company Description
Edesa Biotech Inc
Edesa Biotech, Inc. is a biopharmaceutical company. It focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company product candidate, EB01, is a sPLA2 inhibitor for the topical treatment of chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness. EB01 employs a novel, non-steroidal mechanism of action and in two clinical studies has demonstrated statistically significant improvement of multiple symptoms in ACD patients. Edesa Biotech was founded in 2007 and is headquartered in Markham, Canada.
---
EDSA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering EDSA
1 Year
1 Year Success Rate
0/16 ratings generated profit
1 Year Average Return
-49.67%
reiterated a buy rating 3 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -49.67% per trade.
---